Viewing Study NCT06184568


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2025-12-25 @ 3:15 PM
Study NCT ID: NCT06184568
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-17
First Post: 2023-12-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module